Holocene Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212M Sell
176,517
-10,842
-6% -$11.1M 0.48% 55
2026
Q1
$172M Buy
187,359
+24,139
+15% +$24.5M 0.42% 65
2025
Q4
$175M Buy
163,220
+13,627
+9% +$13M 0.37% 71
2025
Q3
$114M Sell
149,593
-530,106
-78% -$394M 0.26% 102
2025
Q2
$530M Buy
679,699
+138,107
+26% +$107M 1.29% 8
2025
Q1
$447M Buy
541,592
+115,278
+27% +$95.9M 1.3% 8
2024
Q4
$329M Sell
426,314
-11,289
-3% -$9.35M 1.05% 13
2024
Q3
$388M Buy
437,603
+315,065
+257% +$283M 1.57% 5
2024
Q2
$111M Buy
122,538
+48,235
+65% +$38.6M 0.46% 71
2024
Q1
$57.8M Sell
74,303
-32,778
-31% -$23.3M 0.21% 141
2023
Q4
$62.4M Buy
107,081
+15,275
+17% +$8.92M 0.24% 128
2023
Q3
$49.3M Buy
+91,806
New +$47.3M 0.22% 140
2021
Q4
Sell
-183,112
Closed -$42.3M 926
2021
Q3
$42.3M Buy
+183,112
New +$45.2M 0.23% 132
2021
Q2
Sell
-103,209
Closed -$19.3M 894
2021
Q1
$19.3M Buy
+103,209
New +$20.2M 0.12% 176
2018
Q2
Sell
-3,282
Closed -$254K 654
2018
Q1
$254K Sell
3,282
-5,284
-62% -$425K 0.01% 434
2017
Q4
$723K Buy
+8,566
New +$729K 0.02% 296

Other funds holding LLY

Holocene Advisors's LLY Position: Q2 2026 in Review

Holocene Advisors reduced its Eli Lilly (LLY) stake by 5.8% in Q2 2026, selling an estimated $11.1M and leaving 176,517 shares worth $212M. The position accounts for 0.48% of the portfolio, ranked #55.

Holocene Advisors first reported a position in LLY in Q4 2017 and has held it in 16 quarters since. The position peaked at $530M in Q2 2025. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Holocene Advisors held 176,517 shares of Eli Lilly worth $212M as of Q2 2026.
  • Holocene Advisors sold 10,842 Eli Lilly shares in Q2 2026, an estimated $11.1M.
  • Eli Lilly made up 0.48% of Holocene Advisors's portfolio in Q2 2026, its #55 holding.
  • Holocene Advisors first reported a position in Eli Lilly in Q4 2017 and has held it in 16 quarters since.
  • Holocene Advisors's Eli Lilly position peaked at $530M in Q2 2025.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.